Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts.

The rate of complications was further highly significant in association with the location of use ( p < 0.001), but did not depend on age, ASA risk classification, BMI, smoking behavior or type of insurance.

also in 132,142 other papers